Meningococcal Conjugate Vaccine Studies May Use Immunologic Correlates

Immunologic correlates may be used to predict protective efficacy of meningococcal conjugate vaccines, FDA's Vaccines and Related Biological Products Advisory Committee agreed at a Sept. 15 meeting in Bethesda, Md.